Good News: EClinCloud Named to the 2026 Future Healthcare 100 "Innovative Health Services and Industry Chain Services Top 100"

On the morning of May 21, the VB100 Awards Ceremony of the 2026 Future Healthcare 100 Conference was held in Shanghai, where the 2026 Future Healthcare 100 list was officially released. Based on its AI innovation capabilities in clinical research, EClinCloud was selected for the "Innovative Health Services and Industry Chain Services Top 100" list.
Recognized by the Industry and Capital Markets
Founded in 2015 and jointly initiated by VB100, VCBeat, and VCBeat Research, the Future Healthcare 100 selection is one of the most influential industry lists and investment bellwethers in China's healthcare sector.
The selection consistently focuses on innovative technologies, industrial value, and growth potential, aiming to identify core innovators representing the future direction of healthcare in China. In 2026, centered on "showcasing, trading, and empowering China's healthcare innovation assets," the selection conducted a comprehensive assessment based on multiple changes in the industry landscape and innovation logic.
This selection fully demonstrates that EClinCloud's overall strength and future potential have earned recognition from both the industry and capital markets.
As an AI technology company in the clinical research field, EClinCloud consistently focuses on real-world pain points across the entire clinical research process and has built a value loop from data to evidence across core products—including eCOA, IRC, EDC, RTSM, CTMS, and eTMF—as well as endpoint assessment services.
This honor stems from the industry's recognition of EClinCloud's professional capabilities and continued exploration. Going forward, we will continue to be driven by AI technology, deepen our focus on clinical research scenarios, and continuously iterate our products and services to support high-quality development in clinical research.


